Treating opioid addiction in jails improves treatment engagement, reduces overdose deaths and reincarceration
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Dec-2025 22:11 ET (31-Dec-2025 03:11 GMT/UTC)
A study supported by the National Institutes of Health (NIH) finds that individuals who received medication for opioid use disorder (MOUD) while incarcerated were significantly more likely to continue treatment six months after release than those who did not receive MOUD. The study also found that receiving MOUD in jail was associated with a 52% lower risk of fatal opioid overdose, a 24% lower risk of non-fatal opioid overdose, a 56% lower risk of death from any cause, and a 12% lower risk of reincarceration after release. These outcomes underscore the importance of providing MOUD treatment during incarceration.
A new Virginia Tech study published in PLOS One establishes a crucial baseline for understanding dog behavior on a large scale.
The research, led by Courtney Sexton, a postdoctoral associate in the Virginia-Maryland College of Veterinary Medicine, and her colleague Yuhuan Li from the University of Washington, utilized four years of owner-reported data from over 47,000 dogs in the Dog Aging Project, a large-scale initiative involving over 40 institutions.
In a three-year study involving more than 5,000 residents of Israel before and after the mass traumatic events of October 7, 2023, those who watched extensive media coverage of the attacks were found to be more likely to develop post-traumatic stress disorder (PTSD). Prof. Erez Shmueli and Prof. Dan Yamin of Tel Aviv University and Wizermed LTD, in collaboration with colleagues from Tel Aviv University and Stanford University present these findings in the open-access journal PLOS Mental Health.